Posts by: Kara Elam

Researchers from Johns Hopkins Kimmel Cancer Center recently presented results from a Phase II clinical trial showing that in patients with colorectal cancers (CRCs) and other cancers for whom standard ... Read more

March 27, 2015March 27, 2015

Ferndale Healthcare’s Education Campaign Brochure Helps Alert Consumers to Signs & Symptoms of Colon Cancer

In 2000, President Clinton announced that March would be officially designated National Colon Cancer (CC) Awareness Month. Since the announcement, March has become a time where public health advocates, healthcare providers, ... Read more

March 11, 2015March 11, 2015

Single-Site Laparoscopic Surgery to Treat Colon Cancer

In 2000, President Clinton announced that March would be officially designated as National Colon Cancer (CC) Awareness Month. Since this announcement was made, March has become a time where ... Read more

March 6, 2015March 6, 2015

Rutgers Cancer Institute Announces Clinical Trial Testing Novel Drug Against Solid Tumors

Rutgers Cancer Institute located in New Brunswick, New Jersey, announced it is opening up enrollment for a new clinical trial to investigate ONC201, a novel anti-cancer drug designed by ... Read more

February 9, 2015February 9, 2015

Study Helps Understand Stem Cell Regulation in Intestinal Cancer

A research team led by Dr. Jorge Moscat, PhD., program director of the Cell Death and Survival Networks Program at Sanford-Burnham Medical Research Institute (Sanford-Burnham), has made an important ... Read more

Posts by: Kara Elam

Kara Elam

Genetic Biomarker May Predict Cancer Patients’ Response to Immunotherapy Drug

Ferndale Healthcare’s Education Campaign Brochure Helps Alert Consumers to Signs & Symptoms of Colon Cancer

Single-Site Laparoscopic Surgery to Treat Colon Cancer

Rutgers Cancer Institute Announces Clinical Trial Testing Novel Drug Against Solid Tumors

Study Helps Understand Stem Cell Regulation in Intestinal Cancer

Pin It on Pinterest